Source link : https://newshealth.biz/health-news/novel-med-tied-to-slowed-decline-in-lewy-body-dementia/

The experimental drug neflamapimod reduced a key biomarker of neurodegeneration, which correlated with a slowing of cognitive and functional decline in patients with DLB, phase 2b trial results show. Medscape Medical News Source link : https://www.medscape.com/viewarticle/novel-med-tied-slowed-decline-lewy-body-dementia-2025a1000yls?src=rss Author : Publish date : 2025-12-10 09:16:00 Copyright for syndicated content belongs to the linked Source.

The post Novel Med Tied to Slowed Decline in Lewy Body Dementia first appeared on News Health.

—-

Author : News Health

Publish date : 2025-12-10 09:16:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678